DM
MNTA

Deerfield Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Deerfield Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,136,645
Closed -$20.1M – 146
2013
Q4 		$20.1M Sell
1,136,645
-871,241
-43% -$14.6M 1.04% 37
2013
Q3 		$28.9M Buy
+2,007,886
New +$30.7M 1.34% 28

Other funds holding MNTA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Deerfield Management's MNTA Position: Q1 2014 in Review

Deerfield Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2014, closing a stake of 1,136,645 shares — an estimated $20.1M sold.

Deerfield Management first reported a position in MNTA in Q3 2013 and held it in 2 quarters. The position peaked at $28.9M in Q3 2013. 158 funds tracked by Wall St. Rank hold MNTA as of Q1 2014.

  • Deerfield Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Deerfield Management sold 1,136,645 Momenta Pharmaceuticals, Inc. shares in Q1 2014, an estimated $20.1M.
  • Deerfield Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 2 quarters.
  • Deerfield Management's Momenta Pharmaceuticals, Inc. position peaked at $28.9M in Q3 2013.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2014.

Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.